Literature DB >> 7696103

Terminal complement complexes in acute poststreptococcal glomerulonephritis.

D G Matsell1, R J Wyatt, L W Gaber.   

Abstract

Activation of the complement cascade occurs in most cases of acute poststreptococcal glomerulonephritis (APSGN) and results in the formation of the terminal complement complexes (TCC). To examine the possible role of TCC in the pathogenesis of glomerular injury in APSGN, we studied 30 patients with the clinical diagnosis of APSGN. All patients had an elevated plasma SC5b-9 concentration at the onset of clinical nephritis. Serial plasma concentrations showed an inverse linear relationship with time after onset of clinical disease (r = -0.59, P = 0.0008), while plasma C3 concentrations showed a positive linear relationship (r = 0.78, P = 0.0001). Renal biopsies of 5 patients demonstrated co-localization of C5b-9, S-protein, and C3 deposition in a glomerular capillary loop and mesangial distribution. Urinary excretion of TCC in the acute phase of APSGN was not elevated and was not a useful marker of disease activity. These data suggest that in APSGN with terminal complement pathway activation the local generation of TCC may contribute to the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7696103     DOI: 10.1007/bf00869086

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  24 in total

1.  SERUM LEVELS OF BETA-1C GLOBULIN, A COMPLEMENT COMPONENT, IN THE NEPHRITIDES, LIPOID NEPHROSIS, AND OTHER CONDITIONS.

Authors:  C D WEST; J D NORTHWAY; N C DAVIS
Journal:  J Clin Invest       Date:  1964-08       Impact factor: 14.808

Review 2.  Growth factors and the mesangium.

Authors:  H E Abboud
Journal:  J Am Soc Nephrol       Date:  1992-04       Impact factor: 10.121

Review 3.  Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects.

Authors:  B P Morgan
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

4.  Immunohistochemical study of complement S protein (Vitronectin) in normal and diseased human kidneys: relationship to neoantigens of the C5b-9 terminal complex.

Authors:  J Bariety; N Hinglais; S Bhakdi; C Mandet; M Rouchon; M D Kazatchkine
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

Review 5.  The membrane attack complex of complement.

Authors:  H J Müller-Eberhard
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

6.  Mesangiocapillary glomerulonephritis associated with meningococcal meningitis, C3 nephritic factor and persistently low complement C3 and C5.

Authors:  S A Hulton; R A Risdon; M J Dillon
Journal:  Pediatr Nephrol       Date:  1992-05       Impact factor: 3.714

7.  Immunohistochemical detection of the terminal C5b-9 complement complex in children with glomerular diseases.

Authors:  H G Rus; F Niculescu; M Nanulescu; A Cristea; P Florescu
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

8.  Plasma C3 and C4 concentrations in management of glomerulonephritis.

Authors:  J S Cameron; R M Vick; C S Ogg; W M Seymour; C Chantler; D R Turner
Journal:  Br Med J       Date:  1973-09-29

9.  Plasma terminal complement complexes in acute poststreptococcal glomerulonephritis.

Authors:  D G Matsell; S Roy; J D Tamerius; P R Morrow; W P Kolb; R J Wyatt
Journal:  Am J Kidney Dis       Date:  1991-03       Impact factor: 8.860

10.  Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat.

Authors:  M Schulze; P J Baker; D T Perkinson; R J Johnson; R F Ochi; R A Stahl; W G Couser
Journal:  Kidney Int       Date:  1989-01       Impact factor: 10.612

View more
  6 in total

Review 1.  Post-streptococcal acute glomerulonephritis in children: clinical features and pathogenesis.

Authors:  T Matthew Eison; Bettina H Ault; Deborah P Jones; Russell W Chesney; Robert J Wyatt
Journal:  Pediatr Nephrol       Date:  2010-07-23       Impact factor: 3.714

2.  A large family with a gain-of-function mutation of complement C3 predisposing to atypical hemolytic uremic syndrome, microhematuria, hypertension and chronic renal failure.

Authors:  Karl Lhotta; Andreas R Janecke; Johanna Scheiring; Barbara Petzlberger; Thomas Giner; Verena Fally; Reinhard Würzner; Lothar B Zimmerhackl; Gert Mayer; Veronique Fremeaux-Bacchi
Journal:  Clin J Am Soc Nephrol       Date:  2009-07-09       Impact factor: 8.237

Review 3.  Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics.

Authors:  Tilo Freiwald; Behdad Afzali
Journal:  Adv Immunol       Date:  2021-11-19       Impact factor: 3.543

Review 4.  Deposition of the Membrane Attack Complex in Healthy and Diseased Human Kidneys.

Authors:  Jacob J E Koopman; Mieke F van Essen; Helmut G Rennke; Aiko P J de Vries; Cees van Kooten
Journal:  Front Immunol       Date:  2021-02-11       Impact factor: 7.561

Review 5.  Management and outcomes of acute post-streptococcal glomerulonephritis in children.

Authors:  Leong Tung Ong
Journal:  World J Nephrol       Date:  2022-09-25

Review 6.  Soluble Membrane Attack Complex: Biochemistry and Immunobiology.

Authors:  Scott R Barnum; Doryen Bubeck; Theresa N Schein
Journal:  Front Immunol       Date:  2020-11-10       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.